Core Laboratories (CLB) Long-Term Investments (2022 - 2025)

Core Laboratories' Long-Term Investments history runs 4 years deep, the most recent figure standing at $4.4 million for Q4 2025.

• On a quarterly basis, Long-Term Investments fell 12.87% year-over-year to $4.4 million in Q4 2025; TTM through Dec 2025 was $4.4 million, a 12.87% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 12.87% from the prior year.
• Long-Term Investments slipped to $4.4 million in Q4 2025 per CLB's latest filing, from $5.1 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $5.1 million in Q4 2024 and bottomed at $4.4 million in Q4 2025.
• The 4-year median for Long-Term Investments is $4.6 million (2022), against an average of $4.7 million.
• Across the five-year window, Long-Term Investments advanced 8.85% in 2023 and slipped 12.87% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $4.4 million in 2022, then grew by 8.85% to $4.8 million in 2023, then climbed by 4.87% to $5.1 million in 2024, then slipped by 12.87% to $4.4 million in 2025.
• Per Business Quant, the three latest CLB Long-Term Investments figures stand at $4.4 million (Q4 2025), $5.1 million (Q4 2024), and $4.8 million (Q4 2023).